Latanoprost 50micrograms/ml eye drops

Ülke: Birleşik Krallık

Dil: İngilizce

Kaynak: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktif bileşen:

Latanoprost

Mevcut itibaren:

Viatris UK Healthcare Ltd

ATC kodu:

S01EE01

INN (International Adı):

Latanoprost

Doz:

50microgram/1ml

Farmasötik formu:

Eye drops

Uygulama yolu:

Ocular

Sınıf:

No Controlled Drug Status

Reçete türü:

Valid as a prescribable product

Ürün özeti:

BNF: 11060000; GTIN: 5013457028102

Bilgilendirme broşürü

Page 1 of 7
PACKAGE LEAFLET: INFORMATION FOR THE USER
LATANOPROST PFIZER 50 MICROGRAMS/ML EYE DROPS, SOLUTION
Latanoprost
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU. EVEN IF YOU HAVE ALREADY USED
LATANOPROST PFIZER OR A SIMILAR
MEDICINE BEFORE, WE ADVISE YOU TO READ THIS TEXT CAREFULLY. THE
INFORMATION MAY HAVE BEEN
CHANGED.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or the doctor
treating your child, or pharmacist.

This medicine has been prescribed for you or for your child only. Do
not pass it on to others. It
may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or the doctor
treating your child, or pharmacist.
This includes any possible side effects not listed in this leaflet.
See section 4.
WHAT IS IN THIS LEAFLET:
1.
What Latanoprost Pfizer is and what it is used for
2.
What you need to know before you use Latanoprost Pfizer
3.
How to use Latanoprost Pfizer
4.
Possible side effects
5.
How to store Latanoprost Pfizer
6.
Contents of the pack and other information
1.
WHAT LATANOPROST PFIZER IS AND WHAT IT IS USED FOR
Latanoprost Pfizer belongs to a group of medicines known as
prostaglandin analogues. It works by
increasing the natural outflow of fluid from inside the eye into the
bloodstream.
Latanoprost Pfizer is used to treat conditions known as OPEN ANGLE
GLAUCOMA and OCULAR
HYPERTENSION in adults. Both of these conditions are linked with an
increase in the pressure within
your eye, eventually affecting your eye sight.
Latanoprost Pfizer is also used to treat increased eye pressure and
glaucoma in all ages of children
and babies.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE LATANOPROST PFIZER
Latanoprost Pfizer can be used in adult men and women (including the
elderly) and in children from
birth to 18 years of age. Latanoprost Pfizer has not been investigated
in prematurely born infants (less
than 3

Ürün özellikleri

OBJECT 1
LATANOPROST PFIZER 50 MICROGRAMS/ML EYE DROPS,
SOLUTION (PRE-FILLED BOTTLE)
Summary of Product Characteristics Updated 09-Apr-2018 | Pfizer
Limited
1. Name of the medicinal product
Latanoprost Pfizer 50 micrograms/ml eye drops, solution.
2. Qualitative and quantitative composition
1 ml of eye drops, solution contains 50 micrograms of latanoprost.
2.5 ml of eye drops, solution (content of a dropper container)
contains 125 micrograms of latanoprost.
One drop contains approximately 1.5 micrograms latanoprost.
Excipient with known effect
0.2 mg benzalkonium chloride/ml eye drops, solution.
For the full list of excipients, see section 6.1.
3. Pharmaceutical form
Eye drops, solution.
The solution is a clear colourless liquid.
4. Clinical particulars
4.1 Therapeutic indications
Reduction of elevated intraocular pressure in patients with open angle
glaucoma and ocular hypertension.
Reduction of elevated intraocular pressure in paediatric patients with
elevated intraocular pressure and
paediatric glaucoma.
4.2 Posology and method of administration
Posology
_Adults (including the elderly)_
Recommended therapy is one eye drop in the affected eye(s) once daily.
Optimal effect is obtained if
Latanoprost Pfizer is administered in the evening.
The dosage of Latanoprost Pfizer should not exceed once daily since it
has been shown that more frequent
administration decreases the intraocular pressure lowering effect.
If one dose is missed, treatment should continue with the next dose as
normal.
Method of administration
As with any eye drops, to reduce possible systemic absorption, it is
recommended that the lachrymal sac
be compressed at the medial canthus (punctal occlusion) for one
minute. This should be performed
immediately following the instillation of each drop.
Contact lenses should be removed before instillation of the eye drops
and may be reinserted after 15
minutes.
If more than one topical ophthalmic medicinal product is being used,
the medicinal products should be
administered at least five minutes apart.
_Paedi